Title : Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.

Pub. Date : 2019 Jul 21

PMID : 31367160






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In these patients, treatment with sorafenib presented better survival when compared to those patients who received sorafenib without prior TACE [HR = 0.26 (CI: 0.09-0.71); P = 0.013]. Sorafenib ADAM metallopeptidase domain 17 Homo sapiens